Genzyme Corporation (NASDAQ: GENZ) announced today that it will reopen enrollment in the Alglucosidase Alfa Temporary Access Program (ATAP), a ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE